Literature DB >> 8889368

Treatment of head and neck cancer: the role of chemotherapy.

D J Adelstein1, E H Tan, P Lavertu.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8889368     DOI： 10.1016/1040-8428(96)00215-6

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  7 in total

1.  Integration of chemotherapy into the definitive management of squamous cell head and neck cancer.

Authors:  D J Adelstein
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

2.  Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

Authors:  Ann Marie Egloff; Ju-Whei Lee; Corey J Langer; Harry Quon; Alec Vaezi; Jennifer R Grandis; Raja R Seethala; Lin Wang; Dong M Shin; Athanassios Argiris; Donghua Yang; Ranee Mehra; John Andrew Ridge; Urjeet A Patel; Barbara A Burtness; Arlene A Forastiere
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531

Review 3.  Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck.

Authors:  C Ko; D Citrin
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

4.  A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.

Authors:  Reinhold Graf; Bert Hildebrandt; Wolfgang Tilly; Hanno Riess; Roland Felix; Volker Budach; Peter Wust
Journal:  BMC Cancer       Date:  2006-02-01       Impact factor: 4.430

Review 5.  Oropharyngeal cancer: the role of chemotherapy.

Authors:  David J Adelstein
Journal:  Curr Treat Options Oncol       Date:  2003-02

6.  Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancer.

Authors:  Joseph I Clark; Joshua B Greene; Ann Lau Clark; Jay S Dalal; Craig C Hofmeister
Journal:  Med Oncol       Date:  2012-12-25       Impact factor: 3.738

Review 7.  MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies.

Authors:  Mahrou Vahabi; Giovanni Blandino; Silvia Di Agostino
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.